Teva Recalls Blood Pressure Medication in the U.S.; Adds to Growing List | dLife
Teva recalls one lot of leukemia med after finding particulates in vial | Fierce Pharma
Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA
Teva Recalls Drug Vials, Shuts Facility Over Mold Concerns - TheStreet
Teva's troubled Godollo plant earns firm US FDA warning letter
RECALL ALERT: FDA Adds to List of Recalled Blood Pressure Drugs - The Diabetes Site News
Report: Two more blood pressure drugs recalled for potential cancer risk
FDA Recall Watch | McIntyre Law PC
FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes
Teva Issues Voluntary Nationwide Recall of One Lot of IDArubicin Hydrochloride Injection USP 5 mg/5 mL Due to the Presence of Particulate Matter | FDA
Dissolution Test Failure Prompts Recall of Anagrelide Capsules - MPR
FDA recalls blood pressure medicine due to potential cancer risk
Metformin recall by FDA: What's the latest news on metformin ER?
Valsartan Blood Pressure Meds Recalled | PrimeMED
Vegas doctor explains blood pressure med recall
Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News
Teva Recalls U.S.-Made Drugs Following Contamination Fears | 2021-10-04 | SupplyChainBrain
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva halts output at U.S. drug plant after FDA flags concerns | Reuters")
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva Pharma Receive Warning Letter - Parker Waichman LLP
/cloudfront-us-east-1.images.arcpublishing.com/gray/UVAUY3N3VBKKPJZ24MSVDZL62I.png "FDA recalls blood pressure medicine due to potential cancer risk")
FDA recalls blood pressure medicine due to potential cancer risk
Teva Pharmaceuticals announces recall of two blood pressure drugs.
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
Teva Recalls One Lot Of IDArubicin Hydrochloride Injection
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
Teva recalls 2 lots of hypertension drug on dissolution issues
FDA: Cancer risk low with recalled valsartan | Clinician Reviews
